Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.059 0.09
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.064 0.09
mRNA PD-0325901 CCLE pan-cancer AAC -0.072 0.09
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.09
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.061 0.09
mRNA salermide CTRPv2 pan-cancer AAC -0.079 0.09
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.063 0.09
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.055 0.1
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.06 0.1
Download CSV